Table 3. Multilevel logistic regression analysis for odds of initiation on TDF-based therapy in 2011–2012.
| Kenya | Uganda | |||
|---|---|---|---|---|
| OR | [95% CI] | OR | [95% CI] | |
| Facility characteristics | ||||
| Private/NGO owner | 0.35 | [0.03,3.81] | 2.86 | [1.45,5.66]** |
| Hospital | 2.83 | [0.71,11.22] | 0.61 | [0.27,1.38] |
| Rural | 0.99 | [0.25,3.98] | 0.63 | [0.32,1.26] |
| Program is over 5 years old | 0.45 | [0.15,1.41] | 1.93 | [0.92,4.02] |
| ART program has physician | 2.29 | [0.51,10.35] | 2.86 | [1.48,5.51]** |
| Nurses can initiate patients | 0.54 | [0.19,1.57] | 1.42 | [0.58,3.44] |
| Staff received HIV training in last year | 1.41 | [0.29,6.76] | 0.8 | [0.42,1.52] |
| Patient characteristics | ||||
| Female | 1.15 | [0.98,1.34] | 0.86 | [0.73,1.02] |
| CD4 recorded at initiation | 1.16 | [0.97,1.39] | 1.43 | [1.16,1.76]** |
| Year of initiation (2012 vs 2011) | 1.59 | [1.30,1.96]** | 2.53 | [2.07,3.09]** |
| Age at initiation (reference: under 30) | ||||
| 30–40 | 1.29 | [1.07,1.55]** | 1.02 | [0.83,1.24] |
| 40–50 | 1.18 | [0.95,1.47] | 1.04 | [0.83,1.32] |
| 50+ | 1.39 | [1.07,1.79]* | 1.31 | [0.98,1.74] |
| WHO stage at initiation (reference: Stage 1) | ||||
| 2 | 1.13 | [0.92,1.38] | 0.88 | [0.70,1.10] |
| 3 | 2.14 | [1.74,2.63]** | 1.28 | [1.00,1.64] |
| 4 | 2.78 | [1.73,4.48]** | 2.15 | [1.46,3.17]** |
| Missing | 1.09 | [0.77,1.54] | 1.24 | [0.90,1.71] |
*p<0.05
**p<0.01
***p<0.001